Page 85 - 85 cell signalling pathways
P. 85

Cell Signalling Biology Michael J. Berridge  Module 2  Cell Signalling Pathways                2  85




             Module 2: Figure ROS microdomains


                                                             BCR
                                                                                 Resting
                                                   SHP1        DUOX  SHP1
                                                 Lyn                        SHP1
                                  SHP1     SHP1                                    SHP1   SHP1
                          SHP1                        Syk     BLNK  PLC  IP 3
                                       SHP1                 Btk              SHP1
                               SHP1                                    2+              SHP1
                                                                     Ca
                                            SHP1
                                      SHP1
                                                 SHP1           SHP1      SHP1
                                                        SHP1                             SHP1
                           SHP1    SHP1                                         SHP1
                                              SHP1
                                                       Antigen
                                                                                  Stimulated
                                                               DUOX  SHP1
                                                 Lyn  SHP1                   SHP1
                                 SHP1      SHP1                                    SHP1   SHP1
                          SHP1                                BLNK  PLC  IP
                                      SHP1            Syk              3  SHP1
                                SHP1                        Btk                 SHP1   SHP1
                                            SHP1                        2+
                                     SHP1              H  O   microdomain  Ca
                                                        2 2
                                                 SHP1                     SHP1
                           SHP1    SHP1                SHP1     SHP1                     SHP1
                                        SHP1  SHP1                              SHP1
                                                                  PROLIFERATION
             Localized ROS signalling in a microdomain surrounding the B cell receptor.
             Under resting conditions, the protein phosphorylation cascade that operates between Lyn, Syk, Bruton’s tyrosine kinase (Btk) and phospholipase C
             (PLC) (Module 2: Figure ROS effects on Ca 2 +  signalling) is inhibited by the tyrosine phosphatase Src homology 2 (SH2) domain-containing protein
             tyrosine phosphatase-1 (SHP-1), which is present at very high levels. When the receptor is stimulated by antigen, there is a Ca 2 + -dependent activation
             of dual oxidase (DUOX) that creates a microdomain of H 2 O 2 (yellow oblong) to inhibit the SHP-1 enzymes in the immediate vicinity of the B cell
             receptor (BCR). This figure is based on information taken from Singh et al. 2005.


             • Synaptic plasticity such as long-term potentiation (LTP)  ible for feeding information into the JNK pathway. The
               in hippocampal neurons                         apoptosis signal-regulating kinase 1 (ASK1) is an example
             • Proliferation of endothelial cells during angiogenesis  of such a kinase that initiates the signalling cascade that
               (Module 9: Figure VEGF-induced proliferation)  leads to JNK activation. One way of trying to cope with
             • Phosphorylation of the transcription factor p53  this complexity is to examine specific examples such as the
               (Module 4: Figure p53 domains)                 activation of JNK by the interleukin-1 receptor (Module
             • Remodelling the ERK signalling pathway may contrib-  2: Figure JNK signalling).
               ute to the development of polycystic kidney disease  The JNK pathway can also be activated through Gpro-
               (Module 12: Figure polycystins and polycystic kidney  tein-coupled receptors (GPCRs) using G proteins such as
               disease)                                       G 12/13 . Just how G proteins feed into the cascade is unclear,
             • Activation of phospholipase A 2 (PLA 2 )in mast cells  but it seems that they activate the GTP-binding proteins
               (Module 11: Figure mast cell signalling)       such as Rac and Cdc42. Alternatively, the arrestins that
                                                              associate with GPCRs during the process of receptor de-
                                                              sensitization may function as a scaffold to bring together
             c-Jun N-terminal kinase (JNK) pathway            components of the JNK pathway such as MKP7 and JNK3.
             The c-Jun N-terminal kinase (JNK) pathway is one of the  The MAPK signalling system operates a negative-
             major signalling cassettes of the mitogen-activated pro-  feedback loop in that some of the genes activated by the
             tein kinase (MAPK) signalling pathway. It functions in the  JNK pathway code for signalling components such as the
             control of a number of cellular processes, including prolif-  scaffold protein JNK-interacting protein 1 (JIP1), which
             eration, embryonic development and apoptosis. The path-  will bind JNK and thus limits its action.
             way takes its name from the c-Jun N-terminal kinases 1--3  This JNK pathway contributes to the control of a large
             (JNK1--JNK3), which are the MAPKs that interact with  number of cellular processes:
             the final effectors (Module 2: Figure MAPK signalling).
             They contain the dual phosphorylation motif Thr-Pro-  • Phosphorylation of the transcription factor p53
             Tyr, which is phosphorylated following activation of the  (Module 4: Figure p53 domains).
             upstream phosphorylation cascade.                • The JNK pathway has been implicated in the
               The JNK pathway is activated by a bewildering number  mitogen-activated protein kinase (MAPK) signalling in
             of mechanisms. This complexity is evident by the fact that  cardiac hypertrophy (Module 12: Figure hypertrophy
             there are 13 MAPK kinase kinases (MAPKKKs) respons-  signalling mechanisms).




             C  2012 Portland Press Limited                                               www.cellsignallingbiology.org
   80   81   82   83   84   85   86   87   88   89   90